Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Pacira BioSciences, Inc.
  6. News
  7. Summary
    PCRX   US6951271005

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Pacira BioSciences Logs Higher Exparel, Iovera Sales in November

12/07/2021 | 08:45am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
PACIRA BIOSCIENCES, INC. 0.67% 61.55 Delayed Quote.2.29%
All news about PACIRA BIOSCIENCES, INC.
05/12Pacira BioSciences Posts Higher Exparel, Lower Iovera Sales in April
MT
05/12Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45..
GL
05/10Pacira BioSciences to Present at Two Healthcare Conferences in May
GL
05/10Pacira BioSciences to Present at Two Healthcare Conferences in May
AQ
05/10Genascence Corporation announced that it expects to receive funding from Pacira BioScie..
CI
05/05RBC Capital Adjusts Pacira BioSciences' Price Target to $81 From $85, Maintains Outperf..
MT
05/04PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
05/04Pacira BioSciences Q1 Non-GAAP EPS, Revenue Higher
MT
05/04TRANSCRIPT : Pacira BioSciences, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04PACIRA : Q1 Earnings Snapshot
AQ
More news
Analyst Recommendations on PACIRA BIOSCIENCES, INC.
More recommendations
Financials (USD)
Sales 2022 707 M - -
Net income 2022 90,4 M - -
Net Debt 2022 25,0 M - -
P/E ratio 2022 33,2x
Yield 2022 -
Capitalization 2 797 M 2 797 M -
EV / Sales 2022 3,99x
EV / Sales 2023 3,36x
Nbr of Employees 697
Free-Float 98,9%
Chart PACIRA BIOSCIENCES, INC.
Duration : Period :
Pacira BioSciences, Inc. Technical Analysis Chart | PCRX | US6951271005 | MarketScreener
Technical analysis trends PACIRA BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 61,55 $
Average target price 80,46 $
Spread / Average Target 30,7%
EPS Revisions
Managers and Directors
David M. Stack Chairman & Chief Executive Officer
Charles A. Reinhart Chief Financial Officer
Roy Winston Chief Medical Officer
Charles Anthony Laranjeira Senior Vice President-Technical Operations
Jonathan Slonin Chief Clinical Officer
Sector and Competitors
1st jan.Capi. (M$)
PACIRA BIOSCIENCES, INC.2.29%2 797
JOHNSON & JOHNSON3.38%465 363
PFIZER, INC.-15.46%280 096
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421